Aino Health AB (publ) (STO:AINO)
0.1200
-0.0030 (-2.44%)
Apr 24, 2026, 5:29 PM CET
Aino Health AB Revenue
In the year 2025, Aino Health AB had annual revenue of 26.11M SEK with 9.07% growth. Aino Health AB had revenue of 5.43M in the quarter ending December 31, 2025, a decrease of -9.55%.
Revenue
26.11M
Revenue Growth
+9.07%
P/S Ratio
0.94
Revenue / Employee
1.37M
Employees
19
Market Cap
24.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.11M | 2.17M | 9.07% |
| Dec 31, 2024 | 23.94M | 21.00K | 0.09% |
| Dec 31, 2023 | 23.92M | 4.01M | 20.15% |
| Dec 31, 2022 | 19.91M | -3.14M | -13.61% |
| Dec 31, 2021 | 23.04M | -2.39M | -9.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.09B |
| Swedish Orphan Biovitrum AB | 28.24B |
| Sectra AB | 3.52B |
| Camurus AB | 2.27B |
| Fluicell AB | 15.22M |
| Luxbright AB | 13.75M |
| Enorama Pharma AB | 2.74M |
| Biosergen AB | 2.09M |